View in EDS

Ready for the challenge: navigating the evolving landscape of GLP-1s for pediatric obesity treatment.

Saved in:
Bibliographic Details
Title: Ready for the challenge: navigating the evolving landscape of GLP-1s for pediatric obesity treatment.
Authors: Burton, E Thomaseo (AUTHOR), Ramos-Velez, Caroll M (AUTHOR), McKelvey, Nicole J (AUTHOR), Estrada, Elizabeth (AUTHOR), Parks, Elizabeth Prout (AUTHOR), Eddington, Angelica R (AUTHOR)
Source: Journal of Pediatric Psychology. May2026, Vol. 51 Issue 5, p438-441. 4p.
Subjects: Glucagon-like peptide-1 agonists, Childhood obesity, Medical research, Integrated health care delivery, Psychological stress, Health behavior, Health equity, Regulation of body weight
Abstract: This article focuses on the evolving role of glucagon-like peptide-1 receptor agonists (GLP-1s), such as liraglutide (Saxenda) and semaglutide (Wegovy), in pediatric weight management for youth aged 12 and older, with potential expansion to younger children. It emphasizes the critical role of pediatric psychologists in supporting behavioral lifestyle management, addressing psychosocial challenges, and ensuring ethical and effective integration of GLP-1 therapy within interdisciplinary care models. The article highlights the need for longitudinal research on psychological and developmental outcomes, the importance of comprehensive clinical approaches combining medication with intensive health behavior and lifestyle treatment, and advocacy to promote equitable access to these therapies amid existing health disparities. Overall, it calls for coordinated efforts in research, clinical practice, and policy to optimize the safe and just use of GLP-1s in treating pediatric obesity. [Extracted from the article]
Copyright of Journal of Pediatric Psychology is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Description
Abstract:This article focuses on the evolving role of glucagon-like peptide-1 receptor agonists (GLP-1s), such as liraglutide (Saxenda) and semaglutide (Wegovy), in pediatric weight management for youth aged 12 and older, with potential expansion to younger children. It emphasizes the critical role of pediatric psychologists in supporting behavioral lifestyle management, addressing psychosocial challenges, and ensuring ethical and effective integration of GLP-1 therapy within interdisciplinary care models. The article highlights the need for longitudinal research on psychological and developmental outcomes, the importance of comprehensive clinical approaches combining medication with intensive health behavior and lifestyle treatment, and advocacy to promote equitable access to these therapies amid existing health disparities. Overall, it calls for coordinated efforts in research, clinical practice, and policy to optimize the safe and just use of GLP-1s in treating pediatric obesity. [Extracted from the article]
ISSN:01468693
DOI:10.1093/jpepsy/jsag002